OpenBilldrug price receipt

NADAC week of 2026-10-14

DEXILANT DR 60 MG CAPSULE

FDA nonproprietary name: dexlansoprazole

For 30 capsules

Pharmacies pay

$295.18 filed

30 × $9.83942 per EA

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare

We don’t know yet

No Medicare reference price. Part D: OpenBill did not match this NDC to a usable Medicare Part D spending row. Either Part D has none for it, or the rows that share its name could not safely be tied to it (for example, they mix units, routes or release forms, or the drug is sold over the counter, which Part D does not cover). Part B: This NDC is not in the current quarter’s Medicare Part B NDC-HCPCS crosswalk, so it has no Part B payment limit.


The spread

We don’t know yet

There is no Medicare figure to compare with, so there is no spread.

Cost-plus estimate

$344.46 estimated

$295.18 + $44.28 (15%) + $5.00 fee per fill = $344.46

This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

DEXILANT DR 60 MG CAPSULE is how the CMS NADAC file names this product. The FDA NDC Directory lists it as dexlansoprazole, under the trade name “Dexilant”.

FDA gives its dosage form as capsule, delayed release and its route as oral.

The labeler, the company named on the label, is Takeda Pharmaceuticals America, Inc.

FDA’s Established Pharmacologic Class for it is Proton Pump Inhibitor.

The NADAC file of 2026-10-14 prices it under 2 NDCs (National Drug Codes).

NADAC classes it as a brand-name drug (rate-setting class B), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $295.18 for 30 capsules (30 × $9.83942 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.

NADAC also lists, on the row of its brand NDCs, what pharmacies pay for the generic equivalent, a different product: $3.70686 per EA filed.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

All 2 NDCs

Other strengths, forms and brands

3 other products in the NADAC file share the FDA nonproprietary name dexlansoprazole with DEXILANT DR 60 MG CAPSULE.

ProductPharmacies pay per unitMedicare per unit
DEXILANT DR 30 MG CAPSULE
brand · capsule, delayed release
$9.8526 per EA filed
eff. 2026-09-23
We don’t know yet
DEXILANT DR 60 MG CAPSULE this page
brand · capsule, delayed release
$9.83942 per EA filed
eff. 2026-09-23
We don’t know yet
DEXLANSOPRAZOLE DR 30 MG CAP
generic · capsule, delayed release pellets / capsule, delayed release
$3.77267 per EA filed
eff. 2026-09-23
$5.06255 per EA filed
Part D 2024 average
DEXLANSOPRAZOLE DR 60 MG CAP
generic · capsule, delayed release pellets / capsule, delayed release
$3.70686 per EA filed
eff. 2026-09-23
$5.06255 per EA filed
Part D 2024 average

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

Compared with its class

The middle of its 2 NDCs’ NADAC prices is $9.83942 per EA filed.

Of the 61 other products in FDA’s Proton Pump Inhibitor class priced per EA, 9 have a higher middle NADAC price and 52 a lower one. The one in the middle is NAPROXEN-ESOMEPRAZ DR 500-20 MG, at $1.95826 per EA filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

What Medicare paid

We don’t know yet; the card above says why.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.